Mark J DiNubile - JoVE Visualize

Showing results (21-30 of 97) with videos related to

Pageof 10

Sort By:

HIV Clinical Trials|October 25, 2007

Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infectionDeborah K McMahon, Mark J Dinubile, Anne R Meibohm, et al.

The Pediatric Infectious Disease Journal|June 4, 2008

Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002

Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazoleNicholas Kartsonis, Mark J DiNubile, Ken Bartizal, et al.

International Journal of Antimicrobial Agents|August 15, 2006

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)Po-Ren Hsueh, Theresa A Snyder, Mark J Dinubile, et al.

Pharmacoepidemiology and Drug Safety|August 6, 2003

Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trialsCarlos Rojas, Paul M Coplan, Thomas Rhodes, et al.

Blood|October 24, 2002

Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantationMark J DiNubile, Thomas P Stossel, Olof C Ljunghusen, et al.

Surgical Infections|January 26, 2006

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)Joseph W Chow, Vilas Satishchandran, Theresa A Snyder, et al.

Antimicrobial Agents and Chemotherapy|January 18, 2002

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiasesEduardo G Arathoon, Eduardo Gotuzzo, L Miguel Noriega, et al.

Antimicrobial Agents and Chemotherapy|July 29, 2005

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infectionsMark J DiNubile, Joseph W Chow, Vilas Satishchandran, et al.

Diagnostic Microbiology and Infectious Disease|March 15, 2011

An unusual outbreak of rotavirus genotype G2P[6] during the 2005-2006 epidemic season in PhiladelphiaH Fred Clark, Diane Lawley, Daniel DiStefano, et al.

Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:

Pageof 10

HIV Clinical Trials|October 25, 2007

Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infectionDeborah K McMahon, Mark J Dinubile, Anne R Meibohm, et al.

The Pediatric Infectious Disease Journal|June 4, 2008

Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002

Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazoleNicholas Kartsonis, Mark J DiNubile, Ken Bartizal, et al.

International Journal of Antimicrobial Agents|August 15, 2006

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)Po-Ren Hsueh, Theresa A Snyder, Mark J Dinubile, et al.

Pharmacoepidemiology and Drug Safety|August 6, 2003

Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trialsCarlos Rojas, Paul M Coplan, Thomas Rhodes, et al.

Blood|October 24, 2002

Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantationMark J DiNubile, Thomas P Stossel, Olof C Ljunghusen, et al.

Surgical Infections|January 26, 2006

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART)Joseph W Chow, Vilas Satishchandran, Theresa A Snyder, et al.

Antimicrobial Agents and Chemotherapy|January 18, 2002

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiasesEduardo G Arathoon, Eduardo Gotuzzo, L Miguel Noriega, et al.

Antimicrobial Agents and Chemotherapy|July 29, 2005

Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infectionsMark J DiNubile, Joseph W Chow, Vilas Satishchandran, et al.

Diagnostic Microbiology and Infectious Disease|March 15, 2011

An unusual outbreak of rotavirus genotype G2P[6] during the 2005-2006 epidemic season in PhiladelphiaH Fred Clark, Diane Lawley, Daniel DiStefano, et al.

Pageof 10